Markuskrankenhaus

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Kidney cancer

Running trials

• Active, not recruiting

  Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

  NCT03647878· Ipsen· Source